Skip to main content
TEVA filings

Corporate insider profile

Evan Lippman Filing Activity

Latest reported as EVP, Business Development of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,162,657.88
Latest transaction
Aug 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 17, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)EVP, Business DevelopmentSale18,600$36.57$680,291
May 14, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)EVP, Business DevelopmentSale41,658$35.58$1,482,367